Janeen Noel Doyle sold $57K of JANX stock

Janeen Noel Doyle, Chief Corp. & Bus. Dev. Ofcr of Janux Therapeutics, Inc. (JANX), sold 4,059 shares of JANX stock worth $57K, per an SEC Form 4 filed Jun 5, 2026.

It was an open-market sale.

The trade happened on Jun 2, 2026, 3 days before it was made public.

JANX has moved -7.4% since the trade date, from $13.78 to $12.76 (Nov 9, 2026 close).